Cryofocus Medtech (Shanghai) Co., Ltd.: Cryofocus Medtech: Steady Increase in Revenue and Gross Profit with Solid R&D Expenditures in 2024
Nearly 10 Product Candidates Under Development are Expected to be Commercialized in the Next Three YearsHONG KONG, Apr 1, 2025 - (JCN Newswire) - Cryofocus Medtech (Shanghai) Co., Ltd. ('Cryofocus Med ...
JCN Newswire14h
Cryofocus Medtech: Steady Increase in Revenue and Gross Profit with Solid R&D Expenditures in 2024
In 2024, Cryofocus Medtech’s revenue has maintained a strong growth trend within the interventional cryotherapy industry. The total revenue of Cryofocus Medtech increased by 30.7% YoY to RMB53.5 ...
Corsicana Daily Sun14h
D. Boral Capital Acted as Sole Bookrunner to EPSIUM ENTERPRISE LIMITED (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering
NEW YORK CITY, NY / ACCESS Newswire / March 31, 2025 / On March. 27, 2025, EPSIUM ENTERPRISE LIMITED (Nasdaq:EPSM) (the ...
Health News Florida16h
How Much Will That Surgery Cost? Hospital Price Lists Remain Largely Unhelpful
Health care price transparency is one of the few bipartisan issues in Washington, D.C. But much of the information is not ...
The Eagle-Tribune18h
Newsmax Begins Trading on NYSE Under Ticker Symbol "NMAX"
BOCA RATON, FL / ACCESS Newswire / March 31, 2025 / Newsmax Inc. ("Newsmax" or the "Company") announced that its Class B Common Stock will begin trading this morning on ...
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, ...